Results 241 to 250 of about 19,656,854 (402)
Risk assessment and risk management [PDF]
openaire +2 more sources
Objective Administrative claims are used to evaluate oral glucocorticoid use in rheumatoid arthritis (RA), despite limited evidence to support accuracy. We aimed to evaluate the performance of claims‐based algorithms for glucocorticoid use compared to self‐report in an RA population.
Beth I. Wallace +16 more
wiley +1 more source
From fixed time points to personalized care: rethinking stroke risk management in atrial fibrillation patients. [PDF]
Mei DA, Imberti JF, Boriani G.
europepmc +1 more source
Production Practice Alternatives for Income and Suitable Field Day Risk Management [PDF]
Carl R. Dillon
openalex +1 more source
Objective Imaging evidence of active sacroiliitis is important for diagnosis, classification, and monitoring of axial spondyloarthritis (axSpA). However, there is no consistent guidance on whether patients should temporarily stop nonsteroidal anti‐inflammatory drugs (NSAIDs) before magnetic resonance imaging (MRI).
Gareth T. Jones +10 more
wiley +1 more source
Risk Management of Medication Errors: Improving the Quality of Pharmacotherapeutic Practice. [PDF]
Despott RA, Vella Bonanno P, Gauci C.
europepmc +1 more source
Clinical risk management: an emerging agenda for psychiatry [PDF]
David J. Roy
openalex +1 more source
Time Trends and Predictors of Gout Remission Over 6 Years
Objective This study aims to describe the trends in remission rates over 6 years of follow‐up among people with gout taking urate‐lowering therapy (ULT) and to identify variables that predict remission. Methods A post hoc analysis was conducted using data from the Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout (CARES) trial ...
Adwoa Dansoa Tabi‐Amponsah +5 more
wiley +1 more source

